XT
AYTU icon

XTX Topco’s AYTU BioPharma AYTU Stock Holding History

XTX Topco’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.9K Sell
21,582
-4,278
-17% -$10.9K ﹤0.01% 3273
2025
Q4 		$67.2K Buy
+25,860
New +$58K ﹤0.01% 2754

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco's AYTU Position: Q1 2026 in Review

XTX Topco reduced its AYTU BioPharma (AYTU) stake by 17% in Q1 2026, selling an estimated $10.9K and leaving 21,582 shares worth $58.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3273.

XTX Topco first reported a position in AYTU in Q4 2025 and has held it in 2 quarters since. The position peaked at $67.2K in Q4 2025. 37 funds tracked by Wall St. Rank hold AYTU as of Q1 2026.

  • XTX Topco held 21,582 shares of AYTU BioPharma worth $58.9K as of Q1 2026.
  • XTX Topco sold 4,278 AYTU BioPharma shares in Q1 2026, an estimated $10.9K.
  • AYTU BioPharma made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3273 holding.
  • XTX Topco first reported a position in AYTU BioPharma in Q4 2025 and has held it in 2 quarters since.
  • XTX Topco's AYTU BioPharma position peaked at $67.2K in Q4 2025.
  • 37 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.